Inzy stock price target
Web20 mrt. 2024 · According to 13 stock analysts, the average 12-month stock price forecast for INZY stock is $ 19.46 , which predicts an increase of 605.07%. The lowest target is $ … Web8 apr. 2024 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The average twelve-month price prediction for Inozyme Pharma is $16.00 with a high …
Inzy stock price target
Did you know?
Web2 aug. 2024 · For Inozyme Pharma stock forecast for 2024, 11 predictions are offered for each month of 2024 with average Inozyme Pharma stock forecast of $2.01, a high … WebThe latest price target for . Inozyme Pharma (NASDAQ: INZY) was reported by Jefferies on Thursday, March 23, 2024.The analyst firm set a price target for 6.00 expecting INZY to …
Web14 apr. 2024 · RenovoRx (NASDAQ:RNXT – Get Rating) and Inozyme Pharma (NASDAQ:INZY – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and … Web6 apr. 2024 · The average price target represents an increase of 262.71% from its latest reported closing price of $5.39. See our leaderboard of companies with the largest price target upside. ... This is a decrease of 11 owner(s) or 13.92% in the last quarter. Average portfolio weight of all funds dedicated to INZY is 0.04%, ...
WebTrade prices are not sourced from all markets. Previous close: 4.93: Open: 4.91: Bid: 0.00 ... 08 May 2024 - 12 May 2024: Forward dividend & yield: N/A (N/A) Ex-dividend date: … WebCurrently 13 wall-street analysts regularly analyze the financials of INOZYME PHARMA INC on a frequent basis to provide recommendations along with target share price. 13 …
Web11 apr. 2024 · BOSTON, April 11, 2024 -- Inozyme Pharma, Inc. , a clinical- stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal... April 11, 2024
Web13 apr. 2024 · The rating they have provided for INZY stocks is “Hold” according to the report published on May 26th, 2024. H.C. Wainwright gave a rating of “Buy” to INZY, … high back reclining sofa single mujiWebWhat is INZY's Price Target? According to 3 Wall Street analyst s that have issued a 1 year INZY price target, the average INZY price target is $16.33, with the highest INZY stock … how far is jupiter from the sun in au\u0027sWeb12 apr. 2024 · Anpario plc (LON:ANP – Get Rating) insider Richard Edwards acquired 25,000 shares of the business’s stock in a transaction on Thursday, April 6th.The shares were bought at an average cost of ... high back reclining patio chair cushionsWebINZY Stock 12 Months Forecast $15.25 (178.28% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Inozyme Pharma in the last 3 months. The average … high back reclining wheelchairWeb2 dagen geleden · Inozyme Pharma - INZY - Stock Price Today - Zacks Inozyme Pharma (INZY) (Delayed Data from NSDQ) $5.89 USD +0.45 (8.27%) Updated Apr 11, 2024 … how far is jupiter from the sun in million kmWeb14 apr. 2024 · The average 12-month price objective among brokerages that have covered the stock in the last year is $83.00. A number of research analysts have recently commented on the stock. Wells Fargo & Company reduced their target price on shares of UMB Financial from $95.00 to $85.00 and set an “equal weight” rating on the stock in a … high backrestWebPrice target. 19.33R USD +15.73 +437.04%. The 6 analysts offering 1 year price forecasts for Inozyme Pharma, Inc. have a max estimate of 40.00 and a min estimate of 6.00. how far is jupiter from earth now